Abstract 464: Assessment of tumor heterogeneity for Integrin beta-6 expression in non-squamous non-small cell lung cancer specimens using an investigational Integrin beta-6 IHC assay.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Agilent Technologies (United States), Pfizer (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148885883
Cites:
Cited by:
Related to: